Carmen Sánchez Matás

Mrs. Carmen Sánchez Matás

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2020 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
MMMauro Malve
Mauro Malve
CMCarmen Sánchez Matás
Carmen Sánchez Matás
JLJ. L. López-Villalobos
J. L. López-Villalobos

1 April 2018 in Journal of Oral Implantology
Verified
Journal Article
Closed access
ASArturo Sánchez-Pérez
Arturo Sánchez-Pérez
JMJesús Muñoz-Peñalver
Jesús Muñoz-Peñalver
MMMaría José Moya-Villaescusa
María José Moya-Villaescusa
CMCarmen Sánchez Matás
Carmen Sánchez Matás
The fear of postoperative pain is often mentioned by patients as one of the factors that is most frequently associated with dental implants. To reduce this factor, a single oral dose of 25 mg dexketoprofen trometamol (DKT) or placebo was administered 15 minutes before implant surgery. One hundred patients who required single-implant treatments were randomly assigned to 1 of 2 blinded groups. The patients in the test group were given 25 mg DKT (DKT group), and those in the control group were given 500 mg vitamin C as a placebo (PLACEBO group). A subjective visual analogue scale of 100 mm in length was used to evaluate pain. Inflammation and complications were assessed using a 5-point Likert scale. An analysis of variance, t-tests, and a Mann-Whitney U test were performed. Among the 100 patients, 83 completed the study (there were 8 dropouts in the PLACEBO group and 9 in the DKT group). The patients who received DKT reported a lower pain intensity during the immediate postoperative period. The inflammatory response was weaker in the DKT group than the control group at 48 hours, but bleeding was greater. There were no other complications in either of the groups. In conclusion, the preemptive use of 25 mg soluble DKT administered orally 15 minutes before implant surgery can reduce the severity of immediate postoperative pain.

1 April 2020 in Journal of Oral Implantology
Verified
Journal Article
Closed access
ASArturo Sanchez-Perez
Arturo Sanchez-Perez
CCCarlos Cachazo-Jiménez
Carlos Cachazo-Jiménez
CMCarmen Sánchez Matás
Carmen Sánchez Matás
JMJosé Javier Martín-De-Llano
José Javier Martín-De-Llano
SDScott Davis
Scott Davis
CCCarmen Carda-Batalla
Carmen Carda-Batalla
This study investigated whether a 6-Watt ultraviolet C-lamp was capable of producing photofunctionalization on commercial implants during a medium observation term of 8 weeks. A total of 20 implants were inserted in 5 New Zealand rabbits, with each animal receiving 2 implants per tibia (one photofunctionalized and one untreated), according to a previously established randomization sequence. All implants were inserted by a single surgeon following the manufacturer's instructions. Histological analysis was performed by an evaluator who was blinded to the treatment condition. After 8 weeks of healing, the 2 groups showed no statistically significant differences in terms of bone-to-implant contact. Compared to control implants, the photofunctionalized implants showed improved wettability and more homogenous results. Within the limits of the present study, the use of this 6-W ultraviolet C-lamp, for an irradiation time of 15 minutes at a distance of 15 cm, did not improve the percentages of bone-to-implant contact in rabbits at an osseointegration time of 8 weeks.

14 June 2024 in Polymers
Verified
Journal Article
Open access
PDF file
AAAda Ayechu-Abendaño
Ada Ayechu-Abendaño
AJAurora Pérez Jiménez
Aurora Pérez Jiménez
CMCarmen Sánchez Matás
Carmen Sánchez Matás
JLJosé Luis López-Villalobos
José Luis López-Villalobos
Cristina DíazCristina Díaz
Cristina Díaz
MMMauro Malve
Mauro Malve
The placement of endotracheal prostheses is a procedure used to treat tracheal lesions when no other surgical options are available. Unfortunately, this technique remains controversial. Both silicon and metallic stents are used with unpredictable success rates, as they have advantages but also disadvantages. Typical side effects include restenosis due to epithelial hyperplasia, obstruction and granuloma formation. Repeat interventions are often required. Biodegradable stents are promising in the field of cardiovascular biomechanics but are not yet approved for use in the respiratory system. The aim of the present study is to summarize important information and to evaluate the role of different geometrical features for the fabrication of a new tracheo-bronchial prosthesis prototype, which should be biodegradable, adaptable to the patient’s lesion and producible by 3D printing. A parametric design and subsequent computational analysis using the finite element method is carried out. Two different stent designs are parameterized and analyzed. The biodegradable material chosen for simulations is polylactic acid. Experimental tests are conducted for assessing its mechanical properties. The role of the key design parameters on the radial force of the biodegradable prosthesis is investigated. The computational results allow us to elucidate the role of the pitch angle, the wire thickness and the number of cells or units, among other parameters, on the radial force. This work may be useful for the design of ad hoc airway stents according to the patient and type of lesion.

1 September 2021 in Mathematics
Verified
Journal Article
Open access
PDF file
JZJesús Zurita-Gabasa
Jesús Zurita-Gabasa
CMCarmen Sánchez Matás
Carmen Sánchez Matás
Cristina DíazCristina Díaz
Cristina Díaz
JLJosé Luis López-Villalobos
José Luis López-Villalobos
MMMauro Malve
Mauro Malve
The management of complex airway disorders is challenging, as the airway stent placement usually results in several complications. Tissue reaction to the foreign body, poor mechanical properties and inadequate fit of the stent in the airway are some of the reported problems. For this reason, the design of customized biomedical devices to improve the accuracy of the clinical results has recently gained interest. The aim of the present study is to introduce a parametric tool for the design of a new tracheo-bronchial stent that could be capable of improving some of the performances of the commercial devices. The proposed methodology is based on the computer aided design software and on the finite element modeling. The computational results are validated by a parallel experimental work that includes the production of selected stent configurations using the 3D printing technology and their compressive test.

3 March 2020 in Materials
Verified
Journal Article
Open access
PDF file
APArturo Sanchez Perez
Arturo Sanchez Perez
ANAna Isabel Nicolas-Silvente
Ana Isabel Nicolas-Silvente
CMCarmen Sánchez Matás
Carmen Sánchez Matás
ECElena Cascales-Pina
Elena Cascales-Pina
VMVanesa Macia-Manresa
Vanesa Macia-Manresa
Georgios RomanosGeorgios Romanos
Georgios Romanos
Two-phase implants must be exposed to the external environment after the period of osteointegration has elapsed. For this purpose, a healing abutment is placed passing through the mucosa while forming the emergence profile. The continuous connection and disconnection can lead to an alteration in the tissue maturation, both because of the contact of bacterial plaque and because of the mechanical trauma that involves its manipulation, manifesting with different degrees of erythema or bleeding. To assess whether this epithelium disruption can be counteracted, a blinded study design was developed on 150 unitary implant patients divided into three groups (n = 50), applying chlorhexidine (group 1), ultraviolet C (UV-C) at a wavelength of 254 nm (group 2)and no treatment as a control group (group 3), during each of the disconnections and connections during the prosthodontic treatment (1 time per week for four weeks). All groups showed a better epithelium aspect at the end of the evaluation. Although there were no statistically significant differences in the degree of inflammation, the UV-C treated group had the lowest plaque accumulation, and the highest was for the chlorhexidine-treated group.